Success Metrics

Clinical Success Rate
94.1%

Based on 16 completed trials

Completion Rate
94%(16/17)
Active Trials
1(5%)
Results Posted
13%(2 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_1
1
5%
Ph phase_4
3
14%
Ph phase_2
6
27%
Ph phase_3
12
55%

Phase Distribution

1

Early Stage

6

Mid Stage

15

Late Stage

Phase Distribution22 total trials
Phase 1Safety & dosage
1(4.5%)
Phase 2Efficacy & side effects
6(27.3%)
Phase 3Large-scale testing
12(54.5%)
Phase 4Post-market surveillance
3(13.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.1%

16 of 17 finished

Non-Completion Rate

5.9%

1 ended early

Currently Active

1

trials recruiting

Total Trials

22

all time

Status Distribution
Active(1)
Completed(16)
Terminated(1)
Other(4)

Detailed Status

Completed16
unknown4
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
22
Active
1
Success Rate
94.1%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (4.5%)
Phase 26 (27.3%)
Phase 312 (54.5%)
Phase 43 (13.6%)

Trials by Status

terminated15%
completed1673%
recruiting15%
unknown418%

Recent Activity

1 active trials
Showing 5 of 22
completedphase_3

Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

NCT00004112
recruitingphase_2

Go-CHOP as the Frontline Therapy for PTCL

NCT05963347
completedphase_3

Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma

NCT00052936
completedphase_3

Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

NCT00004179
completedphase_3

SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma

NCT00004031
View all 22 trials

Clinical Trials (22)

Showing 20 of 22 trialsScroll for more
NCT00004112Phase 3

Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

Completed
NCT05963347Phase 2

Go-CHOP as the Frontline Therapy for PTCL

Recruiting
NCT00052936Phase 3

Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma

Completed
NCT00004179Phase 3

Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Completed
NCT00004031Phase 3

SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma

Completed
NCT00064116Phase 3

Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma

Completed
NCT00002565Phase 3

Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma

Completed
NCT03631862Phase 4

Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Unknown
NCT01664975Phase 4

Treatment of Peripheral T-cell Lymphoma

Completed
NCT01949818Phase 4

Treatment of Diffuse Large B Cell Lymphoma

Unknown
NCT00854568Phase 3

Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL

Completed
NCT00002557Phase 2

Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides

Unknown
NCT00003578Phase 3

High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma

Unknown
NCT00005867Phase 3

Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

Completed
NCT00003541Phase 1

Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma

Completed
NCT00003150Phase 3

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma

Completed
NCT00003595Phase 3

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma

Completed
NCT00003784Phase 2

S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Completed
NCT00060385Phase 2

Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma

Terminated
NCT00079261Phase 2

Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma

Completed

Drug Details

Intervention Type
DRUG
Total Trials
22